<DOC>
	<DOC>NCT01684423</DOC>
	<brief_summary>The purpose of this study is to find out whether rivaroxaban is safe to use in children and how long it stays in the body. There will also be a check for bleeding and worsening of blood clots.</brief_summary>
	<brief_title>Oral Rivaroxaban in Children With Venous Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Children aged 6 to &lt; 18 years who have been treated for at least 2 months or, in case of catheterrelated thrombosis, for at least 6 weeks with LMWH (low molecular weight heparin), fondaparinux and/or VKA (vitamin K antagonist) for documented symptomatic or asymptomatic venous thrombosis Hemoglobin, platelets, creatinine and alanine aminotransferase (ALT) and total bilirubin evaluated within 10 days prior to randomization Informed consent provided and, if applicable, child assent provided Active bleeding or high risk for bleeding contraindicating anticoagulant therapy Symptomatic progression of venous thrombosis during preceding anticoagulant treatment Planned invasive procedures, including lumbar puncture and removal of non peripherally placed central lines during study treatment An estimated glomerular filtration rate (eGFR) &lt; 30 mL/min/1.73 m2 Hepatic disease which is associated with coagulopathy leading to a clinically relevant bleeding risk or ALT &gt; 5x upper level of normal (ULN) or total bilirubin &gt; 2x ULN with direct bilirubin &gt; 20% of the total Platelet count &lt; 50 x 10^9/L Hypertension defined as &gt; 95th age percentile Life expectancy &lt; 3 months Concomitant use of strong inhibitors of both cytochrome P450 isoenzyme 3A4 (CYP3A4) and Pglycoprotein (Pgp), i.e. all human immunodeficiency virus protease inhibitors and the following azole antimycotics agents: ketoconazole, itraconazole, voriconazole, posaconazole, if used systemically Concomitant use of strong inducers of CYP3A4, i.e. rifampicin, rifabutin, phenobarbital, phenytoin and carbamazepine</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>